BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $22.03 million.

GUIDANCE:

BioLife Solutions sees FY2025 revenue of $95.5-99 million, versus the consensus of $95.45 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.